HETERO

Production of anti-retroviral and anti-cancer pharmaceuticals in Russia.

About HETERO

HETERO is a Healthcare company. Production of anti-retroviral and anti-cancer pharmaceuticals in Russia. HETERO offers products and services including Anti-Retroviral Drugs and Anti-Cancer Drugs. Its focus areas include Manufacturing, API and Formulations, Oncology Drugs and Pharmaceuticals. Its legal entity in India is ООО 'ΠœΠΠšΠ˜Π—-ЀАРМА' (U99999MH1977PLC010754).

Company details

HETERO is recognized for its role in manufacturing a wide range of anti-retroviral and anti-cancer drugs at affordable prices, with operations centered in Russia. The primary production site, operated by ООО МАКИЗ-ФАРМА in Moscow, focuses on creating non-sterile forms like tablets and capsules that adhere to global standards. Quality control is handled by independent experts, and collaborations with partners are emphasized to enhance access to effective treatments. Efforts are directed towards building full-cycle production facilities that support modern healthcare needs, ensuring safety and efficacy in all products.

Products & Services of HETERO

HETERO offers a comprehensive portfolio of products and services, including Anti-Retroviral Drugs and Anti-Cancer Drugs.

Anti-Retroviral Drugs
Pharmaceutical Products

Anti-retroviral drugs are manufactured for affordable treatment of viral conditions

Anti-Cancer Drugs
Oncology Treatments

Various anti-cancer medications are produced in forms such as tablets and infusions for effective disease management

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Hetero

Premium access

Complete news archive for HETERO

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about HETERO

HETERO is recognized for its role in manufacturing a wide range of anti-retroviral and anti-cancer drugs at affordable prices, with operations centered in Russia. The primary production site, operated by ООО ΠœΠΠšΠ˜Π—-ЀАРМА in Moscow, focuses on creating non-sterile forms like tablets and capsules that adhere to global standards. Quality control is handled by independent experts, and collaborations with partners are emphasized to enhance access to effective treatments. Efforts are directed towards building full-cycle production facilities that support modern healthcare needs, ensuring safety and efficacy in all products.

HETERO offers Anti-Retroviral Drugs and Anti-Cancer Drugs.

HETERO operates through ,.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available